Causes of Death among HIV-Infected Adults Registered in Selected Anti-Retroviral Therapy Centers in North-Eastern India


Background: Causes of death related studies in HIV infected population are necessary to devise disease specific preventive interventions at both state and national level HIV programs. This study examines the causes of death among HIV-infected individuals registered at selected Anti-Retroviral Therapy (ART) centers in the era of treatment in north-eastern India. Data and Methods: A retrospective chart review of causes of death was undertaken among HIV-infected patients who were treated between January 2006 and November 2012 at three selected ART centers in Assam, a north-eastern state of India. Reported causes of death were coded as per the guidelines of the International Classification of Diseases (ICD-10) to determine the deaths to standard definitions. Results: Among 5612 HIV-infected patients registered over a period of 71 months, 370 deaths have occurred. Tuberculosis (28%) was the leading cause of death followed by death due to AIDS related complex (11%), wasting syndrome and multiple infections (9% each). Deaths due to selected causes were significantly associated with patient’s use of alcohol, WHO clinical stage, CD4 count at the time of diagnosis, presence of opportunistic infections during treatment and ART adherence. Median survival duration was shortest among patients who had CD4 count <50 at the start of ART (2.9 months) and patients who had multiple opportunistic infections during treatment (2.5 months). Discussion: Majority (67%) of deaths in our study were due to AIDS-related causes. Tuberculosis has remained the leading cause of death among the HIV patients on ART. Strengthening the linkages and referral between the HIV and TB program will be crucial to reduce the AIDS-related deaths attributed to tuberculosis.

Share and Cite:

Bhattacharjya, C. , Sahu, D. , Kishor Patel, S. , Saggurti, N. and Pandey, A. (2015) Causes of Death among HIV-Infected Adults Registered in Selected Anti-Retroviral Therapy Centers in North-Eastern India. World Journal of AIDS, 5, 90-99. doi: 10.4236/wja.2015.52011.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Palella, F.J., Delaney, K.M., Moorman, A.C., et al. (1998) Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection. New England Journal of Medicine, 338, 853-860.
[2] Krentz, H., Kliewer, G. and Gill, M. (2005) Changing Mortality Rates and Causes of Death for HIV-Infected Individuals Living in Southern Alberta, Canada from 1984 to 2003. HIV Medicine, 6, 99-106.
[3] Palella, F.J., Baker, R.K., Moorman, A.C., et al. (2006) Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study. Journal of Acquired Immune Deficiency Syndromes, 43, 27-34.
[4] Cain, K.P., Anekthananon, T., Burapat, C., et al. (2009) Causes of Death in HIV-Infected Persons Who Have Tuberculosis, Thailand. Emerging Infectious Diseases, 15, 258-264.
[5] Bachani, D., Garg, R., Rewari, B.B., Hegg, L., Rajasekaran, S., et al. (2010) Two-Year Treatment Outcomes of Patients Enrolled in India’s National First-Line Antiretroviral Therapy Programme. National Medical Journal of India, 23, 7-12.
[6] National AIDS Control Organization (2012) Technical Report India HIV Estimates. New Delhi.
[7] Kumarasamy, N., Solomon, S., Chaguturu, S.K., Cecelia, A.J., Vallabhaneni, S., Flanigan, T.P., et al. (2005) The Changing Natural History of HIV Disease: Before and After the Introduction of Generic Antiretroviral Therapy in Southern India. Clinical Infectious Diseases, 41, 1525-1528.
[8] Teja, V.D., Sudha, T. and Lakshmi, V. (2007) Causes and Pattern of Mortality in HIV-Infected, Hospitalized Patients in a Tertiary Care Hospital: A Fourteen Year Study. Indian Journal of Medical Sciences, 61, 555-561.
[9] Ghate, M., Deshpande, S., Tripathy, S., Nene, M., Gedam, P., Godbole, S., et al. (2009) Incidence of Common Opportunistic Infections in HIV-Infected Individuals in Pune, India: Analysis by Stages of Immunosuppression Represented by CD4 Counts. International Journal of Infectious Diseases, 13, e1-e8.
[10] Chakraborty, N., Mukherjee, A., Santra, S., Sarkar, R.N., Banerjee, D., Guha, S.K., Chakraborty, S. and Bhattacharyya, S.K. (2008) Current Trends of Opportunistic Infections among HIV-Seropositive Patients from Eastern India. Japanese Journal of Infectious Diseases, 61, 49-53.
[11] Venkatesh, K.K., Saghayam, S., Devaleenal, B., Poongulali, S., Flanigan, T.P., Mayer, K.H. and Kumarasamy, N. (2012) Spectrum of Malignancies among HIV-Infected Patients in South India. Indian Journal of Cancer, 49, 176-180.
[12] Aggarwal, P., Sharma, A., Bhardwaj, R. and Raina, R. (2009) Myocardial Dysfunction in Human Immunodeficiency Virus Infection: An Echocardiographic Study. The Journal of the Association of Physicians of India, 57, 745-746.
[13] Stewart, A., Carusone, S.C., To, K., McDaniel, N.S., Halman, M. and Grimes, R. (2012) Causes of Death in HIV Patients and the Evolution of an AIDS Hospice: 1988-2008. AIDS Research and Treatment, 2012, 1-7.
[14] Rupali, P., Mannam, S., Bella, A., John, L., Rajkumar, S., Clarence, P., et al. (2012) Risk Factors for Mortality in a South Indian Population on Generic Antiretroviral Therapy. Journal of the Association of Physicians of India, 60, 11-14.
[15] University of Bristol (2010) Introduction to SPSS (Version 16) for Windows: Practical Work Book. University of Bristol Information Services, USA, March, 2010.
[16] Rajagopalan, N., Suchitra, J.B., Shet, A., Khan, Z.K., Martin, G.J., Nonnemacher, M.R., et al. (2009) Mortality among HIV-Infected Patients in Resource Limited Settings: A Case-Controlled Analysis of Inpatients in a Community Care Centre. American Journal of Infectious Diseases, 5, 219-224.
[17] Hosegood, V., Vanneste, A.M. and Timaeus, I.M. (2004) Levels and Causes of Adult Mortality in Rural South Africa: The Impact of AIDS. AIDS, 18, 663-671.
[18] Pacheco, A.G., Tuboi, S.H., May, S.B., Moreira, L.F.S., Ramadas, L., Nunes, E.P., et al. (2009) Temporal Changes in Causes of Death among HIV-Infected Patients in the HAART Era in Rio De Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes, 51, 624-630.
[19] Lewden, C., Salmon, D., Morlat, P., Bevilacqua, S., Jougla, E., Bonnet, F., et al. (2005) Causes of Death among Human Immunodeficiency Virus (HIV)-Infected Adults in the Era of Potent Antiretroviral Therapy: Emerging Role of Hepatitis and Cancers, Persistent Role of AIDS. International Journal of Epidemiology, 34, 121-130.
[20] Jain, M.K., Skiest, D.J., Cloud, J.W., Jain, C.L., Burns, D. and Berggren, R.E. (2003) Changes in Mortality Related to Human Immunodeficiency Virus Infection: Comparative Analysis of Inpatient Deaths in 1995 and in 1999-2000. Clinical Infectious Diseases, 36, 1030-1038.
[21] Ingle, L.M., May, M.T., Gill, M.J., Mugavero, M.J., Lewden, C., Abgrali, S., et al. (2014) Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy among HIV-Infected Patients. Clinical Infectious Diseases, 59, 287-297.
[22] Kassa, A., Teka, A., Shewaamare, A. and Jerene, D. (2012) Incidence of Tuberculosis and Early Mortality in a Large Cohort of HIV Infected Patients Receiving Antiretroviral Therapy in a Tertiary Hospital in Addis Ababa, Ethiopia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 106, 363-370.
[23] Gajalakshmi, V. and Peto, R. (2009) Smoking, Drinking and Incident Tuberculosis in Rural India: Population-Based Case-Control Study. International Journal of Epidemiology, 38, 1018-1025.
[24] Jürgen, R., Andriy, V.S., Manuela, G.N., Robin, R., Charles, P., Knut, L., Patra, J., Poznyak, V. and Popova, S. (2009) The Association between Alcohol Use, Alcohol Use Disorders and Tuberculosis (TB). A Systematic Review. BMC Public Health, 9, 450.
[25] O’Connell, R., Chishinga, N., Kinyanda, E., Patel, V., Ayles, H., Weiss, H.A. and Seedat, S. (2013) Prevalence and Correlates of Alcohol Dependence Disorder among TB and HIV Infected Patients in Zambia. PLoS ONE, 8, e74406.
[26] Lonnroth, K., Jaramillo, E., Williams, B.G., Dye, C. and Raviglione, M. (2009) Drivers of Tuberculosis Epidemics: The Role of Risk Factors and Social Determinants. Social Science & Medicine, 68, 2240-2246.
[27] Jensen, F.S., Pedersen, L., Pedersen, C., Larsen, C.S., Tauris, P., MØller, A., SØrensen, H.T. and Obel, N. (2004) Low Mortality in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy: A Comparison with the General Population. AIDS, 18, 89-97.
[28] Egger, M., May, M., Chêne, G., Phillips, A.N., Ledergerber, B., Dabis, F., Costagliola, D., D’Arminio, M.A., De, W.F., Reiss, P., Lundgren, J.D., Justice, A.C., et al. (2002) ART Cohort Collaboration. Prognosis of HIV-1-Infected Patients Starting Highly Active Antiretroviral Therapy: A Collaborative Analysis of Prospective Studies. The Lancet, 13, 119- 129.
[29] Okongo, M., Morgan, D., Mayanja, B., Ross, A. and Whitworth, J. (1998) Causes of Death in a Rural, Population-Based Human Immunodeficiency Virus Type 1 (HIV-1) Natural History Cohort in Uganda. International Journal of Epidemiology, 27, 698-702.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.